BLEAK MEDTECH FUTURE
03/09/25 -"Medtechs are going nowhere. The post Covid darlings are no longer much in demand. This is made obvious in the following performance chart. Trumpian ambitions to slash health costs while slapping high ..."
Pages
59
Language
English
Published on
03/09/25
You may also be interested by these reports :
03/09/25
In our previous teaser in early 2024, we focused on the impact of generative AI on the Higher Education segment, which was the hottest topic at the ...
01/09/25
We have revised our valuation of Teleperformance downward, incorporating all available information from the FY24 report and recent communications. ...
21/08/25
2Q25: Sales and earnings below expectations. FY25E guidance confirmation
11/08/25
RELX and Wolters Kluwer were again down by 2-4% on Friday, and we think it is related to a (wrong) cross-read from Gartner’s H1 report for RELX and ...